Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade B 89.0 -3.28% -3.02
EXAS closed down 3.28 percent on Friday, March 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical EXAS trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Multiple of Ten Bearish Other 0.00%
Mar 21 Crossed Above 20 DMA Bullish -3.28%
Mar 21 Multiple of Ten Bullish Other -3.28%
Mar 20 Fell Below 20 DMA Bearish -1.64%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.64%
Mar 20 Multiple of Ten Bullish Other -1.64%
Mar 20 Down 3 Days in a Row Weakness -1.64%
Mar 20 Down 4 Days in a Row Weakness -1.64%
Mar 19 MACD Bearish Signal Line Cross Bearish -2.36%

Older signals for EXAS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Medicine Health Cancer Medical Tests Inflammatory Bowel Disease Pancreatic Cancer Colorectal Cancer Cancer Screening Diagnostic Gastroenterology Polyp
Is EXAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 97.27
52 Week Low 37.36
Average Volume 1,740,994
200-Day Moving Average 71.8519
50-Day Moving Average 86.7534
20-Day Moving Average 91.0845
10-Day Moving Average 92.542
Average True Range 3.7122
ADX 17.37
+DI 24.2568
-DI 24.7104
Chandelier Exit (Long, 3 ATRs ) 86.1334
Chandelier Exit (Short, 3 ATRs ) 91.9166
Upper Bollinger Band 97.8182
Lower Bollinger Band 84.3508
Percent B (%b) 0.35
BandWidth 14.785611
MACD Line 1.4173
MACD Signal Line 1.8977
MACD Histogram -0.4804
Fundamentals Value
Market Cap 10.59 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -68.99
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.96
Resistance 3 (R3) 95.15 93.36 93.96
Resistance 2 (R2) 93.36 91.84 93.26 93.63
Resistance 1 (R1) 91.18 90.91 90.29 90.99 93.30
Pivot Point 89.39 89.39 88.94 89.29 89.39
Support 1 (S1) 87.21 87.87 86.32 87.02 84.70
Support 2 (S2) 85.42 86.94 85.32 84.37
Support 3 (S3) 83.24 85.42 84.04
Support 4 (S4) 83.05